Shanghai, China · Founded 2021 · Privately Held (backing)
Developer of cellular therapy designed for human pluripotent stem cells. UniXell Biotechnology is based in Shanghai, China and was founded in 2021. It has raised $66.6 million.
Last price · $/share
—
Implied valuation
—
Total raised
$66.6M
Last round
—
Team — not yet on record
No current team members for UniXell Biotechnology are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of UniXell Biotechnology with a free account
·The complete investor list: 21 names
·Watch UniXell Biotechnology: the Monday email on marks, rounds and moves
